SOD3 and persistent fetal circulation syndrome: On the contrary, treatment with recombinant catalase enhanced SOD3 activity, impaired due to SOD3 oxidative modification, and reduced oxidative stress as well as improved oxygenation in lambs with persistent pulmonary hypertension of the newborn (PPHN) [174].